[ad_1]
WASHINGTON. Aspirin, used at low doses, could reduce the severity of symptoms and immune system abnormalities in patients with multiple sclerosis, having proven its effectiveness during an experiment in mice.
That's according to a study published today in the magazine Scientific signage.
According to research, aspirin administered orally to laboratory mice reduced the severity of symptoms, slowed the breakdown of myelin and inhibited cell infiltration into the spinal cord.
The amount of aspirin applied to the mice was equivalent to a dose of the infant version of the drug in adults.
Multiple sclerosis is a degenerative disease that affects more than 2.3 million people worldwide and is caused by the loss of myelin, a protein in the nervous system responsible for transmitting electrical impulses and protecting neurons. .
Researchers from Rush University (Chicago) have discovered an unknown effect of this drug commonly used to relieve pain.
With a small amount, aspirin was able to stimulate the production of positive cells for nerve transmission, while slowing the activity of these malignant cells -Tregg- that attack the nervous system, degrade the metabolism and are responsible for the imbalance that causes the symptoms of multiple sclerosis.
The scientific team, led by Susanta Mondal, noted the safety of the active ingredient in aspirin and its ease of administration, so that it can be reused as a supportive treatment for multiple sclerosis patients and patients with multiple sclerosis. Other autoimmune disorders associated with dysfunction of the same Treg cells.
[ad_2]
Source link
